Patents by Inventor Stephen Fitzhugh Carroll

Stephen Fitzhugh Carroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for quantifying LBP in body fluids
    Patent number: 7081334
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: July 25, 2006
    Assignee: Xoma Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Method for quantifying BPI in body fluids
    Patent number: 6759203
    Abstract: The present invention provides a method for quantifying the presence of extracellular BPI in body fluids including blood in a subject comprising conducting a BPI immunoassay on body fluid sample obtained from said subject.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: July 6, 2004
    Assignee: XOMA Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
    Publication number: 20040002452
    Abstract: Improved therapeutic uses for N-terminal BPI protein products are described in patients that have BPI-reactive anti-neutrophil cytoplasmic antibodies.
    Type: Application
    Filed: November 19, 2002
    Publication date: January 1, 2004
    Applicant: XOMA Technology Ltd.
    Inventor: Stephen Fitzhugh Carroll
  • Therapeutic uses of BPI protein products in cystic fibrosis patients
    Publication number: 20030194377
    Abstract: Improved therapeutic uses and formulations for BPI protein products are described in cystic fibrosis patients.
    Type: Application
    Filed: January 10, 2000
    Publication date: October 16, 2003
    Inventors: Stephen Fitzhugh Carroll, Patrick J. Scannon, Patrick D. Gavit
  • Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
    Patent number: 6482796
    Abstract: Improved therapeutic uses for N-terminal BPI protein products are described in patients that have BPI-reactive anti-neutrophil cytoplasmic antibodies.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: November 19, 2002
    Assignee: Xoma Corporation
    Inventor: Stephen Fitzhugh Carroll
  • Method for quantifying LBP in body fluids
    Publication number: 20020127622
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Application
    Filed: November 26, 2001
    Publication date: September 12, 2002
    Applicant: XOMA Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-Kuen Ma
  • THERAPEUTIC USES OF N-TERMINAL BPI PROTEIN PRODUCTS IN ANCA-POSITIVE PATIENTS
    Publication number: 20020119918
    Abstract: Improved therapeutic uses for N-terminal BPI protein products are described in patients that have BPI-reactive anti-neutrophil cytoplasmic antibodies.
    Type: Application
    Filed: February 22, 1999
    Publication date: August 29, 2002
    Inventor: STEPHEN FITZHUGH CARROLL
  • Method for quantifying LBP in body fluids
    Patent number: 6274328
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Grant
    Filed: September 3, 1998
    Date of Patent: August 14, 2001
    Assignee: Xoma Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Bactericidal/permeability-increasing protein (BPI) deletion analogs
    Patent number: 6013631
    Abstract: Novel BPI deletion analogs are provided that consist of amino acid residues 10 through 193 of mature human BPI wherein the cysteine residue at BPI amino acid position 132 is replaced by another amino acid. Fusion proteins comprising these analogs are also provided, as are polynucleotides encoding these products, materials and methods for their recombinant production, compositions and medicaments of these products, and therapeutic uses for these products.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: January 11, 2000
    Assignee: XOMA Corporation
    Inventors: Arnold Horwitz, Stephen Fitzhugh Carroll, David Burke
  • Method for quantifying LBP in body fluids
    Patent number: 5891618
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: April 6, 1999
    Assignee: XOMA Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Method of screening for an active inflammatory state by determining the concentration of extracellular BPI
    Patent number: 5821064
    Abstract: The present invention provides a method for quantifying the presence of extracellular BPI in body fluids including blood in a subject comprising conducting a BPI immunoassay on body fluid sample obtained from said subject.
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: October 13, 1998
    Assignee: XOMA Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
  • Method for quantifying LBP in body fluids
    Patent number: 5804367
    Abstract: The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
    Type: Grant
    Filed: January 24, 1995
    Date of Patent: September 8, 1998
    Assignee: Xoma Corporation
    Inventors: Mark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma